Clinical Trial Update: Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging [Phase 1]

View source ↗

Summary

A Mayo Clinic–led Phase 1 trial evaluating cardiac resynchronization with iodine meta-iodobenzylguanidine (MIBG) imaging in congestive heart failure was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Mayo Clinic | Conditions: Congestive Heart Failure | Phase 1 | Status: TERMINATED